Improving quality control in PET drug manufacturing.
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
This study is working to make it easier and faster to produce important PET drugs used in medical imaging, so that patients can get the tests they need without delays.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trace-Ability, INC. NIH-funded |
| Lab location | 1 site (Van Nuys, United States) |
| Project ID | NIH-10675471 on NIH RePORTER |
What this research studies
This project aims to enhance the production of PET drugs, which are crucial for diagnostic imaging in various medical conditions. By modernizing the quality control processes, the research seeks to overcome current challenges in throughput and regulatory compliance faced by PET drug manufacturers. The approach involves expanding a previously successful solution, Tracer-QC, to accommodate a wider range of PET drugs, thereby streamlining the manufacturing process and ensuring consistent quality. This could lead to more efficient production and availability of essential imaging products for patients.
Who could benefit from this research
Good fit: Patients requiring diagnostic imaging that utilizes PET drugs would be ideal candidates to benefit from this research.
Not a fit: Patients who do not require PET imaging or those whose conditions are not addressed by PET drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to a wider variety of high-quality PET imaging products for patients.
How similar studies have performed: Previous research has shown success with the Tracer-QC solution for a specific PET tracer, indicating potential for broader application in the industry.
Where this research is happening
Van Nuys, United States
- Trace-Ability, INC. — Van Nuys, United States (Active)
Researchers
- Principal investigator: Elizarov, Arkadij — Trace-Ability, INC.
- Study coordinator: Elizarov, Arkadij
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.